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Abstract Drug resistance has become a global phenome-
non in gastrointestinal nematodes of sheep, particularly
resistance to macrocyclic lactones. New anthelmintics are
urgently needed for both the control of infections with
multi-resistant nematodes in areas where classical anthel-
mintics are no longer effective, and the prevention of the
spread of resistance in areas where the problem is not as
severe. Recently, two new active ingredients became
commercially available for the treatment of nematode
infections in sheep, monepantel (Zolvix®) and derquantel,
the latter used only in a formulated combination with the
macrocyclic lactone, abamectin (Startect®). In order to
assess the potential of the new actives for the control and
prevention of spread of anthelmintic resistance, two
characterized multi-resistant field isolates from Australia
were used in a GLP (good laboratory practice) conducted
efficacy study in sheep. Eight infected sheep in each group
were treated orally according to the product labels with
2.5 mg/kg body weight monepantel, 0.2 mg/kg abamectin,
or with the combination of 2.0 mg/kg derquantel and
0.2 mg/kg abamectin. The results demonstrate that mon-
epantel was fully effective against multi-resistant species,
Trichostrongylus colubriformis and Haemonchus contortus
(99.9%). In contrast, the combination of derquantel and
abamectin was effective against T. colubriformis (99.9%),
but was not effective against larval stages of the barber's
pole worm H. contortus (18.3%).
Introduction
Drug resistance in gastrointestinal nematodes is a severe
global problem for sheep farmers, and in particular
resistance of pathogenic nematodes to the macrocyclic
lactones (MLs); Besier and Love 2003; Yue et al. 2003;
Sargison et al. 2005; Wrigley et al. 2006; Blake and Coles
2007. The MLs were introduced into the market in the early
1980s as the third broad-spectrum anthelmintic class.
However, resistance of nematodes to MLs is now reported
frequently from all major sheep farming countries (Besier
2007). The advent of new compounds with anthelmintic
activity was urgently needed for both the control of
gastrointestinal nematodes resistant to the classical broad-
spectrum drugs, and to help delay the development of drug
resistance in regions where this phenomenon is not yet a
major problem.
Monepantel is the first novel anthelmintic compound for
sheep from a new chemical class (Kaminsky et al. 2008a, b)
and was introduced to the market as Zolvix® (Novartis
Animal Health Inc.) in 2009. The second anthelmintic
compound from another class is derquantel, which was
introduced into the market in 2010 as Startect® (Pfizer
Animal Health), a combination of derquantel and abamec-
tin, a long-known ML. While the spectrum and efficacy of
monepantel has been well documented (Hosking et al.
2008, 2009a, b, 2010; Kaminsky et al. 2009; Mason et al.
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2009; Sager et al. 2009, 2010; Jones et al. 2010), there is
little information published on the spectrum of efficacy of
derquantel (Little et al. 2010). Of particular interest is the
efficacy of these new compounds against ML-resistant
nematodes. The objective of the present study was to
determine the efficacy of monepantel and derquantel
against ML-resistant nematodes in order to evaluate their
potential in the control of such parasites and in delaying the
development of drug resistance in sheep nematodes.
Materials and methods
Thirty-two ruminating, gastrointestinal nematode-free
sheep (as assessed by fecal egg counts) were used in the
study. Two recent field isolates of sheep nematodes from
Australia were used for experimental infection of the study
animals: Haemonchus contortus (Haecon-51) was isolated
in June 2008 and Trichostrongylus colubriformis (Tricol-
56) in January 2009. Both isolates were shown in vivo to be
resistant to benzimidazoles, levamisole, and MLs. All
animals were infected intraruminally with 6,000 third-
stage larvae of Tricol-56 and 3,000 third-stage larvae of
Haecon-51 5 days prior to treatment. The nematode
infections were, therefore, at the fourth-larval stage at
treatment. Eight animals were treated orally with mone-
pantel in a 2.5% (w/v) formulation (Novartis Animal Health
Inc., CH-4002 Basel, Switzerland) at the minimum recom-
mended dose of 2.5 mg/kg. A second group of eight sheep
received abamectin (oral formulation 0.08% (w/v); Ancare
Ireland Limited, Dublin, Ireland) at the recommended
minimum dose of 0.2 mg/kg. A third group (n=8) was
treated with a commercially formulated oral combination of
derquantel and abamectin (1% (w/v) derquantel and 0.1%
(w/v) abamectin; Pfizer New Zealand Limited, Auckland,
New Zealand) at the minimum recommended dose of 2 mg/
kg and 0.2 mg/kg, respectively. Eight animals were left
untreated and served as controls.
Twenty-four days after infection, fecal samples were
collected from all animals and worm egg counts performed
as described by Kaufmann (1996). On the two subsequent
days, the animals were euthanized and worm counts were
completed on the abomasum and small intestine contents as
described in Hosking et al. (2008). In order to assess
efficacy, the arithmetic and geometric mean counts from
each group were used in Abbott's formula (Abbott 1925).
Statistical significance was evaluated with a two-tailed
Mann–Whitney U test (SAS® procedure npar1way, SAS
9.2 Help and Documentation, SAS Institute Inc. Cary, NC,
SAS Institute Inc., 2002–2009) on fecal egg and worm
counts.
The study was performed blinded according to the VICH
guidelines 7 and 13 (anonymous, 1999, 2000; Vercruysse et
al. 2001) under the principles of good laboratory practice
(GLP) (anonymous, 2005).
Results
The results of the fecal egg count reductions are summa-
rized in Table 1. The average reduction of egg counts was
54% in the abamectin-treated group and 58% in the
derquantel/abamectin combination group. Reduction in the
monepantel-treated group was 100%, and this differed
significantly from the control and other treated groups
(Table 2).
The reduction of worm burdens after treatment of the
fourth-stage larval nematodes is summarized in Table 3.
Monepantel had an efficacy of 99.9% against both H.
contortus and T. colubriformis. The combination treatment
of derquantel and abamectin had an efficacy of 18.3%
against H. contortus and 99.9% against T. colubriformis.
Similarly, abamectin alone had an efficacy of 15.3% against
H. contortus and 90.8% against T. colubriformis. While the
worm count reduction for H. contortus in the monepantel-
treated group was highly significant to all other groups
(Table 4), there was no significant difference between the
monepantel- and the derquantel/abamectin-treated groups
for T. colubriformis. Both groups had highly significant
worm count reductions compared to the control and
abamectin-treated groups (Table 5).
Table 1 Fecal egg counts (FEC)
FEC FEC-Efficacy (%)
AMean SEM (±) GMean AMean GMean
Control 2944 528 2390
MPL 0 0 0 100 100
ABA 1356 262 1067 53.9 55.3
DER+ABA 1225 322 430 58.4 82.0
AMean arithmetic mean; GMean geometric mean; SEM standard error
of the mean; MPL monepantel; ABA abamectin; DER derquantel
Table 2 Mann–Whitney U test (P values, FEC)
Vs. Control MPL ABA DER+ABA
Control – 0.0004 0.0207 0.0156
MPL – – 0.0004 0.0015
ABA – – – 0.7524
DER+ABA – – – –
MPL monepantel; ABA abamectin; DER derquantel
Significance is considered for P values≤0.05, high significance if
P≤0.01
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Discussion
The objective of this study was to determine the efficacy
of the recently developed anthelmintics, monepantel, and
derquantel against ML-resistant nematodes. The results
of this study on the efficacy of monepantel confirm those
of previous studies (summarized in Hosking et al. 2010).
Due to its unique mode of action (Kaminsky et al. 2008a;
Rufener et al. 2009), monepantel is highly efficacious
against gastrointestinal nematodes, including those resis-
tant to MLs. The efficacy of 99.9% against the ML-
resistant H. contortus isolate is in agreement with 100%
efficacy observed against two well-characterized resistant
H. contortus isolates (Kaminsky et al. 2008b), as well as
with the >99% pooled efficacy data, including ML-
resistant nematodes from controlled laboratory and field
studies (summarized in Hosking et al. 2010). The
efficacy of monepantel in these studies was independent
of the life stage of the nematode, and was observed
against the adult and larval stages, as was confirmed in
the present study.
The results of the presented study on the efficacy of the
combination treatment of derquantel and abamectin show
that this combination has no efficacy against fourth-stage
larvae of the ML-resistant H. contortus isolate used. The
efficacy of abamectin alone was 15.3%, and 18.3% when
used in combination with derquantel (Table 3). Underlying
worm counts for both groups did not differ significantly (p=
1.000; Table 4). In the study published by Little et al. (2010),
the combination was efficacious against four Haemonchus
isolates (as determined by fecal egg count reduction);
however, all of these Haemonchus isolates were also
sensitive to the ML ivermectin. It remains undetermined if
the observed efficacy of the combination was due to
derquantel or due to the ML abamectin. Unfortunately, the
contribution of each active in the combination to efficacy
was not determined in this study.
The efficacy of abamectin alone or in combination with
derquantel against T. colubriformis differed. Abamectin had
an efficacy of 90.8%, and the combination treatment
resulted in 99.9% efficacy. The ML-resistance in the
Tricol-56 isolate is border-line, just below the 95%
definition level described by Coles et al. (1992). Thus,
derquantel appears to have efficacy against fourth larval
stages of T. colubriformis with a minor degree of ML-
resistance, but clearly has no efficacy against fourth-stage
ML-resistant H. contortus.
The results presented herein indicate that the combina-
tion of derquantel with abamectin has potential to control T.
colubriformis, which cannot be fully eliminated with
abamectin alone. However, the combination of derquantel
with abamectin will not be able to control all infections
with ML-resistant H. contortus.
Furthermore, this combination may also not be effective
in delaying the development of drug-resistance if H.
contortus is present. This is particularly indicated by the
reduction of fecal egg counts (Table 1). There were a high
number of eggs excreted from nematodes in sheep treated
with the combination of derquantel and abamectin, which
developed from larval stages to mature egg-laying adults.
This poses a risk that resistant alleles from nematodes,
which were not cured by the combination treatment, will be
Haemonchus contortus Trichostrongylus colubriformis
GMean AMean GMean AMean
Control (worm counts ± SEM) 2316 (−) 2349 (140) 3369 (−) 3401 (178)
MPL (efficacy) 99.98 99.8 99.9 99.8
ABA (efficacy) 15.3 15.0 90.8 89.6
DER+ABA (efficacy) 18.3 17.1 99.97 99.93
Table 3 Worm counts and
calculated efficacy (%)
AMean arithmetic mean; GMean
geometric mean; SEM standard
error of the mean; MPL mon-
epantel; ABA abamectin; DER
derquantel
Table 4 Mann–Whitney U test (P values, H. contortus)
Vs. Control MPL ABA DER+ABA
Control – 0.0006 0.1272 0.0831
MPL – – 0.0006 0.0006
ABA – – – 1.0000
DER+ABA – – – –
MPL monepantel; ABA abamectin; DER derquantel
Significance is considered for P values≤0.05, high significance if
P≤0.01
Table 5 Mann–Whitney U test (P values, T. colubriformis)
Vs. Control MPL ABA DER+ABA
Control – 0.0008 0.0009 0.0007
MPL – – 0.0008 0.2016
ABA – – – 0.0007
DER+ABA – – – –
MPL monepantel; ABA abamectin; DER derquantel
Significance is considered for P values≤0.05, high significance if
P≤0.01
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selected and ultimately contaminate the pasture, and thus,
increase the resistant worm population.
Emodepside, another anthelmintic with a new mode of
action, has been shown to be effective against drug-resistant
nematodes, including ML-resistant H. contortus (von
Samson-Himmelstjerna et al. 2005) and would have the
potential to be used in resistance control programs.
Unfortunately, emodepside is not available for nematode
control in sheep yet.
The results presented herein show that monepantel can
be used to control ML-resistant H. contortus and T.
colubriformis infections. Furthermore, the reduction of
worm egg counts to zero (Table 1) demonstrates that
monepantel is a suitable compound in resistance manage-
ment programs to delay the onset of development of drug
resistance. Monepantel has been reported to have efficacy
not only against H. contortus and T. colubriformis, but to
adult and larval stages of all the key gastrointestinal
nematode species (summarized in Hosking et al. 2010),
and can, therefore, be used as a broad-spectrum anthelmin-
tic in sheep infected with any of these parasites.
It remains to be investigated if the efficacy of derquantel
against ML-resistant nematodes is limited to T. colubrifor-
mis isolates or whether this could be extended to other
species. Little et al. (2010) have reported on reduced
efficacy (<95%) against larval and adult Teladorsagia
(=Ostertagia) circumcincta. Here, we report on the lack
of efficacy of the combination of derquantel and abamectin
against ML-resistant H. contortus (<20%). Further studies
are required to determine if the lack of efficacy of this
combination is restricted to T. circumcincta and fourth-
stage H. contortus or also other nematodes. It is important
for veterinarians and other animal health advisors to know
the spectrum of efficacy of the available compounds for the
design of anthelmintic control programs.
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